GlobeNewswire 7/22/2025 Fury Reports Encouraging Metallurgical Test Results from the Ninaaskumuwin Lithium Discovery at Elme...
GlobeNewswire 7/13/2025 Panama Announces Emergence as the Next Premier Destination for Luxury Real Estate Investment
TMX Newsfile 7/2/2025 Sale Completion of Non-Core Irish Assets for CAD$ 2.5 million
GlobeNewswire 6/30/2025 The Bouzy Group Announces Westin-Branded Residences Near Panama City, Offering New Investment Opport...
GlobeNewswire 6/26/2025 BioVie Highlights Patient-Centric Design of SUNRISE-PD Trial at Advanced Therapeutics in Movement & ...
GlobeNewswire 6/24/2025 BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at the Advanced Therapeutics in Movement & Re...
GlobeNewswire 6/24/2025 LKQ Corporation and SYNETIQ, an IAA Company Announce Strategic European Joint Venture
GlobeNewswire 6/10/2025 Axsome Therapeutics Announces Availability of SYMBRAVO® (meloxicam and rizatriptan) for the Acute Tr...
GlobeNewswire 6/5/2025 Diginex Limited Signs MOU to Acquire Resulticks for US$2bn, transforming AI and Data Management Capa...
GlobeNewswire 6/4/2025 ROHM Develops Breakthrough AI-Equipped MCU
GlobeNewswire 5/20/2025 EverCommerce Appoints Amy Guggenheim Shenkan to Its Board of Directors
GlobeNewswire 5/15/2025 Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2025 and Provides Bu...
GlobeNewswire 5/14/2025 BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Par...
GlobeNewswire 5/7/2025 BioVie to Present Rationale and Design of Phase 2 SUNRISE-PD Clinical Trial at the 30th World Congre...
GlobeNewswire 5/5/2025 BioVie Unveils Corporate Advisory Board Featuring Neuralink Co-Founder, Former Executives from Maste...
GlobeNewswire 5/5/2025 Regeneration Biomedical to Present Updated Phase 1 Trial Data on Autologous Stem Cell Therapy Inject...
GlobeNewswire 4/22/2025 Zurab Tsereteli, Internationally Acclaimed Artist and Friend of Wolf Popper LLP, Dies at 91
GlobeNewswire 4/16/2025 BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease with Fi...
GlobeNewswire 4/15/2025 Radiance Announces First Patient Dosing in Phase 1 Clinical Trial of its Next Generation ROR-1 Targe...
GlobeNewswire 4/15/2025 Scilex Holding Company Announces Approval of a New Drug Submission (NDS) from the Health Canada’s Ph...
GlobeNewswire 4/1/2025 REPEAT -- Radiance Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of RB-164...
GlobeNewswire 4/1/2025 Sky Quarry Reports 4th Quarter and Fiscal Year 2024 Financial Results
GlobeNewswire 3/31/2025 Radiance Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of RB-164™, an ROR-...
GlobeNewswire 3/25/2025 Comstock Settles Strategic Commitments and Strengthens Balance Sheet
GlobeNewswire 3/19/2025 Comstock Announces 2025 Annual Meeting and Record Date